SUPN Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.

$24.19  -0.93 (-3.70%)
As of 03/04/2021 15:59:18 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Drug Manufacturers—Specialty &
USA
USA
05/01/2012
52,685,121
592,657
$1,323,450,240
0.00%
SEC Edgar Online
10-Q
10-K
868459108
US8684591089
B72ZBG4

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
10.43
1.78
2.54
17.04%
24.39%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy